EP Patent
EP3769765A4 — PHARMACEUTICAL COMPOSITION CONSISTING OF SODIUM ALKYL SULPHATE
Assigned to Taiho Pharmaceutical Co Ltd · Expires 2021-12-15 · 4y expired
What this patent protects
Patent listed against Lytgobi.
Drugs covered by this patent
- Lytgobi (futibatinib) · Taiho Oncology
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.